Andrew K. Ressler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Andrew K. Ressler has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Douglas A. Marchuk
Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, USA
13 shared publications - Anabel Martínez-Romero
Josep Carreras Leukaemia Research Institute 3 Barcelona
10 shared publications - Asunción Vicente
Department of Dermatology, Hospital Sant Joan de Déu, Barcelona, Spain
10 shared publications - Carlota Rovira
Department of Pathology, Hospital Sant Joan de Déu, Barcelona, Spain
10 shared publications - Emanuele M. Nola
Endothelial Pathobiology and Microenvironment, Josep Carreras Leukaemia Research Institute, Barcelona, Spain
10 shared publications - Eulalia Baselga
Hospital Sant Joan de Déu Barcelona Spain
10 shared publications
Latest Publications
- 27 March 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (5)
TIE2 links MEKK3–KLF2/4 and PI3K signaling in cerebral cavernous malformation
Cerebral cavernous malformations (CCMs) are vascular lesions in the central nervous system that can cause strokes and seizures. Aggressive CCM growth follows an endothelial cell two-hit mechanism in which enhanced MEKK3–KLF2/4 signaling stimulates PI3K signaling, but how these pathways are linked has been undefined. Here, we use human CCM specimens, two mouse models of CCM disease, and primary human endothelial cells to examine the roles of the major endothelial growth factor receptors, VEGFR2 and TIE2. We find no evidence of augmented VEGFR2 signaling in CCM lesions, and neither genetic nor pharmacologic blockade of VEGFR2 reduced CCM formation in mouse models. Instead, we observe markedly increased phospho-TIE2 levels in human and mouse CCM lesions, MEKK3–KLF2/4-driven induction of TIE2 receptor expression, and almost complete rescue of CCM formation following genetic or pharmacologic TIE2 blockade in mouse models. Our studies identify TIE2 as the molecular link between the MEKK3–KLF2/4 and PI3K signaling pathways during CCM formation and suggest that targeting TIE2 may be an effective means to treat human CCM disease.
- 27 March 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (5)
TIE2 links MEKK3–KLF2/4 and PI3K signaling in cerebral cavernous malformation
Cerebral cavernous malformations (CCMs) are vascular lesions in the central nervous system that can cause strokes and seizures. Aggressive CCM growth follows an endothelial cell two-hit mechanism in which enhanced MEKK3–KLF2/4 signaling stimulates PI3K signaling, but how these pathways are linked has been undefined. Here, we use human CCM specimens, two mouse models of CCM disease, and primary human endothelial cells to examine the roles of the major endothelial growth factor receptors, VEGFR2 and TIE2. We find no evidence of augmented VEGFR2 signaling in CCM lesions, and neither genetic nor pharmacologic blockade of VEGFR2 reduced CCM formation in mouse models. Instead, we observe markedly increased phospho-TIE2 levels in human and mouse CCM lesions, MEKK3–KLF2/4-driven induction of TIE2 receptor expression, and almost complete rescue of CCM formation following genetic or pharmacologic TIE2 blockade in mouse models. Our studies identify TIE2 as the molecular link between the MEKK3–KLF2/4 and PI3K signaling pathways during CCM formation and suggest that targeting TIE2 may be an effective means to treat human CCM disease.
- Open Access
- 9 December 2025
- Published by Springer Nature in Human Genomics
- Vol. 20 (1)
Recurrent somatic copy number alterations in resected cerebral cavernous malformations
Cerebral Cavernous Malformations (CCMs) are brain vascular lesions that occur in sporadic or inherited (autosomal dominant) forms. The malformations are dr
- 9 December 2025
- Published by Springer Nature in Human Genomics
- Vol. 20 (1)
Open AccessRecurrent somatic copy number alterations in resected cerebral cavernous malformations
Cerebral Cavernous Malformations (CCMs) are brain vascular lesions that occur in sporadic or inherited (autosomal dominant) forms. The malformations are dr
- Open Access
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
Loss of endothelial PTEN protein expression in vascular malformations of patients with PHTS.
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
Loss of endothelial PTEN protein expression in vascular malformations of patients with PHTS.
- Open Access
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
PTEN loss in ECs causes lymphatic vascular malformations in the ear skin of mice.
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
PTEN loss in ECs causes lymphatic vascular malformations in the ear skin of mice.
- Open Access
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
Preclinical study of alpelisib in mice with PTEN-related vascular malformations.
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
Preclinical study of alpelisib in mice with PTEN-related vascular malformations.
- Open Access
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
Clinical characteristics of vascular malformations in patients with PHTS; related to Figure 1.
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
Clinical characteristics of vascular malformations in patients with PHTS; related to Figure 1.
- Open Access
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
Patients with PHTS treated with rapamycin; related to Figure 4.
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
Patients with PHTS treated with rapamycin; related to Figure 4.
- Open Access
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
Somatic allelic imbalance analysis using MoChA.
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
Somatic allelic imbalance analysis using MoChA.
- Open Access
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
PTEN loss in ECs causes blood vascular malformations in mice.
- 3 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
PTEN loss in ECs causes blood vascular malformations in mice.